{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00771",
      "entity_text" : "EML4-ALK",
      "features" : [ {
        "to_base" : "A",
        "site" : 0,
        "feature_type" : "mutation",
        "evidence" : "mutation"
      } ],
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_0023" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "The fact that the normal NSCLC A549 cells survived over 80% in each group indicates that this combination therapy is selective to cancer cells expressing higher levels of EML4 ALK mutation than ALK fusion negative cells.",
  "reading_complete" : "2020-08-03T09:43:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:42:25Z",
  "trigger" : "levels",
  "evidence" : [ "levels of EML4-ALK" ],
  "pmc_id" : "5956997",
  "score" : 0
}